Helicobacter pylori infections
Conditions
Interventions
Experimental group:Esomeprazole + Furazolidone Tablets
Control group:Esomeprazole + bismuth potassium citrate granules + Amoxicillin Capsules + Furazolidone Tablets
Sponsors
Nanfang Hospital, Southern Medical University, Guangzhou, China.
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 70 years, male and female; 2. Clinical diagnosis of Helicobacter pylori infection; 3. C13 insufflation test or rapid urease test is positive.
Exclusion criteria
Exclusion criteria: (1) Antibiotics, PPI, expectorant or non-steroidal anti-inflammatory drugs have been used within one month; (2) Pregnancy or lactation; (3) Allergic to the drugs used in the study; (4) Combined with a serious underlying disease or other disease that may lead to treatment failure; (5) With a history of gastrointestinal surgery, or a recent history of other types of surgery; (6) Having a family history of genetic disease, a history of mental illness, etc.; (7) Subjects are participating in other research topics; (8) The investigator believes that other reasons are not suitable for continuing clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the eradication rate of Helicobacter pylori; | — |
Countries
China
Contacts
Public ContactBai Yang
Nanfang Hospital, Southern Medical University
Outcome results
None listed